Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFNS in Uncomplicated Acute Rhinosinusitis
NCT01018030Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2010
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 12
01
Overview
A Phase 2 trial of fluticasone in acute rhinosinusitis (ARS), sponsored by GSK. Started Jan 2010; status: completed.
02
Drugs
fluticasone
03
Conditions
acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on NCT01018030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018030.